第一单位：
Department of Internal Medicine, Inflammation-Immunopathology-Biotherapy Department (DHU i2B), Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Antoine, 184, rue du Faubourg Saint-Antoine, 75012 Paris, France Sorbonne Université, France; Sorbonne Universités, INSERM U938, Centre de Recherche Saint-Antoine (CRSA), Paris, France.
作者：
Anne Laure,Roupie [1]
;
Hubert,de Boysson [2]
;
Sara,Thietart [3]
;
Fabrice,Carrat [4]
;
Julie,Seguier [5]
;
Louis,Terriou [6]
;
Mathilde,Versini [7]
;
Viviane,Queyrel [7]
;
Matthieu,Groh [8]
;
Ygal,Benhamou [9]
;
Francois,Maurier [10]
;
Olivier,Decaux [11]
;
Maud,d'Aveni [12]
;
Julien,Rossignol [13]
;
Joris,Galland [10]
;
Eric,Solary [13]
;
Lise,Willems [14]
;
Nicolas,Schleinitz [5]
;
Lionel,Ades [15]
;
Azeddine,Dellal [16]
;
Maxime,Samson [17]
;
Achille,Aouba [2]
;
Pierre,Fenaux [15]
;
Olivier,Fain [1]
;
Arsène,Mekinian [18]
;
On behalf MINHEMON (French Network of dysimmune disorders associated with hemopathies)
作者单位：
Department of Internal Medicine, Inflammation-Immunopathology-Biotherapy Department (DHU i2B), Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Antoine, 184, rue du Faubourg Saint-Antoine, 75012 Paris, France Sorbonne Université, France; Sorbonne Universités, INSERM U938, Centre de Recherche Saint-Antoine (CRSA), Paris, France.
[1]
Department of Internal Medicine, CHU Caen, Avenue de la côte de nacre, 14033 Caen, France.
[2]
Department of Internal Medicine, Inflammation-Immunopathology-Biotherapy Department (DHU i2B), Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Antoine, 184, rue du Faubourg Saint-Antoine, 75012 Paris, France Sorbonne Université, France.
[3]
Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique IPLESP, AP-HP, Hôpital Saint Antoine, F75012 Paris, France.
[4]
Department of Internal Medicine, CHU Marseille, Marseille, France.
[5]
Department of Internal Medicine, CHU Lille, Lille, France.
[6]
Department of Internal Medicine, CHU Nice, Nice, France.
[7]
Department of Internal Medicine, National Referral Center for Hypereosinophilic Syndromes (CEREO), Foch hospital, Suresnes, France.
[8]
Department of Internal Medicine, CHU Rouen, Rouen, France.
[9]
Department of Internal Medicine, Hôpitaux Privés de Metz, Metz, France.
[10]
Department of Internal Medicine, CHU Rennes, Rennes, France.
[11]
Department of Hematology, CHU Nancy, Nancy, France.
[12]
Department of Hematology, Gustave Roussy Cancer Center, 94805 Villejuif, France.
[13]
Department of Hematology, Assistance Publique-Hôpitaux de Paris, Hôpital Cochin, 75014 Paris, France.
[14]
Department of Hematology, Assistance Publique-Hôpitaux de Paris, Hôpital Saint Louis, 1 avenue Claude Vellefaux, 75010 Paris, France.
[15]
Department of Rheumatology, Montfermeil Hospital, 93370 Montfermeil, France.
[16]
Department of Internal Medicine, CHU Dijon, Dijon, France.
[17]
Department of Internal Medicine, Inflammation-Immunopathology-Biotherapy Department (DHU i2B), Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Antoine, 184, rue du Faubourg Saint-Antoine, 75012 Paris, France Sorbonne Université, France; Sorbonne Universités, INSERM U938, Centre de Recherche Saint-Antoine (CRSA), Paris, France. Electronic address: arsene.mekinian@aphp.fr.
[18]
DOI
10.1016/j.autrev.2019.102446
PMID
31838164
发布时间
2020-02-28
换一批
换一批
